Who makes Minprostin?

Minprostin is developed by Glostrup University Hospital, Copenhagen.

What development phase is Minprostin in?

Minprostin is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Minprostin

Glostrup University Hospital, Copenhagen · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	Minprostin
Sponsor	Glostrup University Hospital, Copenhagen
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

The Balloon Project for Birth Induction (PHASE4)
Labour Induction With Misoprostol, Dinoprostone and Bard Catheter (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Minprostin CI brief — competitive landscape report
Minprostin updates RSS · CI watch RSS
Glostrup University Hospital, Copenhagen portfolio CI